Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture ProcessJan Spanholtz, Harry Dolstra, Frank Preijers et al.|PLoS ONE|2011Cited by 239
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia PatientsHarry Dolstra, Nicolaas Schaap, Mieke W.H. Roeven et al.|Clinical Cancer Research|2017Cited by 211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future DevelopmentsJohn P. Veluchamy, Jan Spanholtz, Nina Kok et al.|Frontiers in Immunology|2017Cited by 197
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer ImmunotherapyJan Spanholtz, Harry Dolstra, Marleen Tordoir et al.|PLoS ONE|2010Cited by 183
Natural killer cells in clinical development as non-engineered, engineered, and combination therapiesNina Lamers-Kok, Monica Raimo, Denise Panella et al.|Journal of Hematology & Oncology|2022Cited by 178